The clinical effect and safety of Tubingen support and Pavlik harness in the treatment of DDH children aged 0-6 months: a multi-center, prospective study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026634

Enrollment

Unknown

Registered

2019-10-16

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Dysplasia of the Hip

Interventions

Group 1:Tubingen

Group 2:Pavlik harness

Eligibility

Sex/Gender

All

Age

No minimum to 0.5 Years

Inclusion criteria

Inclusion criteria: 1. DDH children aged 0-6 months; 2. Graf type IIc,d, III, IV; 3. IHDI type II, III, IV.

Exclusion criteria

Exclusion criteria: 1. Neuromuscular Hip Dysplasia or other musculoskeletal diseases; 2. Mild dysplasia type II (type IIa+, type IIa- and type IIb); 3. Hip pyogenic arthritis. with dislocation; 4. Age > 6 months; 5. Other systemic diseases; 6. Received other treatment; 7. Parents refuse to join the group or the follow-up time of patients is less than 6 months.

Design outcomes

Primary

Measure	Time frame
Graf classification;IHDI classification;Acetabular Index;Lateral center-edge angle;Extrusion index;Shenton line;avascular necrosis of femoral head;	—

Countries

China

Contacts

Public ContactKANG XIAO PENG

Kunming Children's Hospital

shedk@163.com+86 18908711978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026